James Shin
Stock Analyst at Deutsche Bank
(0.93)
# 3,638
Out of 4,735 analysts
18
Total ratings
25%
Success rate
-6.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly | Maintains: Buy | $1,025 → $1,015 | $742.35 | +36.73% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $274.81 | +10.99% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $73.47 | -18.33% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $57.04 | -21.11% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $34.67 | +73.06% | 1 | May 23, 2024 | |
| GILD Gilead Sciences | Initiates: Hold | $75 | $92.96 | -19.32% | 1 | Nov 9, 2023 | |
| ABBV AbbVie | Initiates: Hold | $150 | $172.61 | -13.10% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $687.80 | +16.31% | 1 | Nov 9, 2023 | |
| MRK Merck & Co. | Initiates: Buy | $115 | $96.24 | +19.49% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $2.19 | +356.62% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.99 | +503.02% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $1.14 | +6,040.35% | 1 | Dec 12, 2022 |
Eli Lilly
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $742.35
Upside: +36.73%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $274.81
Upside: +10.99%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $73.47
Upside: -18.33%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $57.04
Upside: -21.11%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $34.67
Upside: +73.06%
Gilead Sciences
Nov 9, 2023
Initiates: Hold
Price Target: $75
Current: $92.96
Upside: -19.32%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $172.61
Upside: -13.10%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $687.80
Upside: +16.31%
Merck & Co.
Nov 9, 2023
Initiates: Buy
Price Target: $115
Current: $96.24
Upside: +19.49%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.19
Upside: +356.62%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $1.99
Upside: +503.02%
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $1.14
Upside: +6,040.35%